IHE Publications
- Cancer
- Chronic Diseases / Disorders
- Community Health Centres
- COVID-19
- Diabetes
- Diagnosis
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Health Technology Assessment
- Health Topic Overviews
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Nurse Practitioners
- Other
- Pharmaceuticals
- Prevention
- Primary Care
- Quality of Life
- Scoping Reviews
- Screening
- Surveillance
- Telehealth
- Therapy
- Akpinar, Ilke
- Bond, Ken
- Brown, Jasmine
- Chojecki, Dagmara
- Corabian, Paula
- Guo, Bing
- Institute of Health Economics, IHE
- McCabe, Christopher
- Moga, Carmen
- Palfrey, Dan
- Pollock, Michelle
- Round, Jeff
- Seida, Jennifer
- Sproule, John
- Sutton, Andrew J.
- Tjosvold, Lisa
- Tran, Dat
- Warkentin, Lindsey
- Wright, Erica
- Yan, Charles
The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease
Little is currently known about the overall health service utilization and cost burden in patients with high risk for cardiovascular disease (HRCVD) who are recommended to start a statin to control dyslipidemia to prevent CVD events and mortality in short- and long-term care. We assessed the resource use and healthcare cost burden in this HRCVD patient population in Alberta, Canada, and found that healthcare costs associated with the conditions is substantial but decreases over time. The long-term care costs are much less than the costs incurred during the first year after diagnosis
Publication Type: Journal Articles
Year of Publication: 2021
Authors: Dan Palfrey, Dat Tran, Robert Welsh
Journal Title: PharmacoEconomics Open